BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026.
Artif Intell Gastrointest Endosc. Sep 8, 2026; 7(2): 118493
Published online Sep 8, 2026. doi: 10.37126/aige.118493
Figure 1
Figure 1 Comparison of artificial intelligence sensitivity for neoplasia detection across commercial non-inflammatory bowel disease systems and inflammatory bowel disease-specific models. Illustrative only, methodological heterogeneity limits direct benchmarking. AI: Artificial intelligence; IBD: Inflammatory bowel disease; CADe: Computer-aided detection.


Write to the Help Desk